FIELD: medicine; pharmaceutics.
SUBSTANCE: dry powder inhalation composition containing at least one API and a lipid matrix containing at least one triglyceride, selected from a group consisting of monohydroxystearin, dihydroxystearin, trihydroxystearin and a mixture thereof, and a method for preparing it.
EFFECT: dry powder inhalation composition and its use for pulmonary drug treatment are proposed.
23 cl, 9 dwg, 31 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CATIONS OF MONOVALENT METALS OF DRY POWDERS FOR INHALATIONS | 2011 |
|
RU2640921C2 |
| DIRECTED DELIVERY OF SPRAY-DRIED COMPOSITIONS INTO THE LUNGS | 2016 |
|
RU2731212C2 |
| ANTIFUNGAL DRY POWDERS | 2017 |
|
RU2766086C2 |
| DRY POWDER COMPOSITIONS REPRESENTED AS PARTICLES WHICH CONTAIN TWO OR MORE ACTIVE INGREDIENTS FOR TREATMENT OF OBSTRUCTIVE OR INFLAMMATORY DISEASES OF RESPIRATORY WAYS | 2012 |
|
RU2629333C2 |
| DEAMORPHIZATION OF SPRAY-DRIED FORMULATIONS VIA SPRAY-BLENDING | 2014 |
|
RU2698331C2 |
| FILLER FOR CAPSULAR INHALER | 2016 |
|
RU2634258C1 |
| NEW CARRIER PARTICLES FOR DRY POWDER COMPOSITIONS FOR INHALATION | 2019 |
|
RU2795231C2 |
| DRY POWDER DRUG DELIVERY SYSTEMS AND METHODS | 2013 |
|
RU2650035C2 |
| DRY POWDER FORMULATIONS AND METHODS OF TREATING PULMONARY DISEASES | 2010 |
|
RU2577698C2 |
| SYSTEMS AND METHODS FOR DRY POWDER DRUG DELIVERY | 2011 |
|
RU2571331C1 |
